Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: Up-regulation of L-arginine transporters

Biochemical Journal

Volumn 449, Issue 1, 2013, Pages 133-142

  Ramachandran, Jayalakshmi ^a   Schneider, Joel S ^a   Crassous, Pierre Antoine ^a   Zheng, Ruifang ^a   Gonzalez, James P ^a   Xie, Lai Hua ^a   Beuve, Annie ^a   Fraidenraich, Diego ^a   Peluffo, R Daniel ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cardiomyopathy; Cationic amino acid transporter (CAT); Mdx mouse; Neuronal nitric oxide synthase (nNOS); Soluble guanylate cyclase (sGC); Utrophin

Indexed keywords

ARGININE; DYSTROPHIN; NITRIC OXIDE; UTROPHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE INACTIVATION; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; ARGININE; CATIONIC AMINO ACID TRANSPORTER 1; CATIONIC AMINO ACID TRANSPORTER 2; FEMALE; MALE; MICE; MICE, INBRED MDX; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCULAR DYSTROPHY, DUCHENNE; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UP-REGULATION; UTROPHIN;

MUS;

EID: 84870905192     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120787     Document Type: Article

References (42)

1. Hoffman, E. P., Brown, Jr., R. H. and Kunkel, L. M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928
2. Gross, S. S. and Wolin, M. S. (1995) Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57, 737-769
3. Bredt, D. S. and Snyder, S. H. (1994) Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63, 175-195
4. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064
5. Bredt, D. S. (2003) Nitric oxide signaling specificity: the heart of the problem. J. Cell Sci. 116, 9-15
6. Adams, M. E., Mueller, H. A. and Froehner, S. C. (2001) In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J. Cell Biol. 155, 113-122 (Pubitemid 34286212)
7. Brenman, J. E., Chao, D. S., Xia, H., Aldape, K. and Bredt, D. S. (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743-752
8. Chang, W. J., Iannaccone, S. T., Lau, K. S., Masters, B. S., McCabe, T. J., McMillan, K., Padre, R. C., Spencer, M. J., Tidball, J. G. and Stull, J. T. (1996) Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 93, 9142-9147 (Pubitemid 26282032)
9. Crosbie, R. H., Barresi, R. and Campbell, K. P. (2002) Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J. 16, 1786-1791 (Pubitemid 35340359)
10. Li, D., Yue, Y., Lai, Y., Hakim, C. H. and Duan, D. (2011) Nitrosative stress elicited by nNOSmicro delocalization inhibits muscle force in dystrophin-null mice. J. Pathol. 223, 88-98
11. Asai, A., Sahani, N., Kaneki, M., Ouchi, Y., Martyn, J. A. J. and Yasuhara, S. E. (2007) Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS ONE 2, e806
12. Xu, K. Y., Huso, D. L., Dawson, T. M., Bredt, D. S. and Becker, L. C. (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 96, 657-662 (Pubitemid 29061264)
13. Kanai, A. J., Pearce, L. L., Clemens, P. R., Birder, L. A., Van Bibber, M. M., Choi, S. Y., de Groat, W. C. and Peterson, J. (2001) Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc. Natl. Acad. Sci. U.S.A. 98, 14126-14131 (Pubitemid 33116035)
14. Duan, D. (2006) Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum. Mol. Genet. 15, R253-R261
15. Ervasti, J. M. (2007) Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim. Biophys. Acta 1772, 108-117
16. Matsumura, K., Ervasti, J. M., Ohlendjeck, K., Kahl, S. D. and Campbell, K. P. (1992) Association of dystrophin-related protein with dystrophin- associated proteins in mdx mouse muscle. Nature 360, 588-591 (Pubitemid 23000708)
17. Yang, B., Jung, D., Rafael, J. A., Chamberlain, J. S. and Campbell, K. P. (1995) Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin. J. Biol. Chem. 270, 4975-4978
18. Li, D., Bareja, A., Judge, L., Yue, Y., Lai, Y., Fairclough, R., Davies, K. E., Chamberlain, J. S. and Duan, D. (2010) Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J. Cell Sci. 123, 2008-2013
19. Quinlan, J. G., Hahn, H. S., Wong, B. L., Lorenz, J. N., Wenisch, A. S. and Levin, L. S. (2004) Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscular Disord. 14, 491-496 (Pubitemid 39141704)
20. Deconinck, A. E., Rafael, J. A., Skinner, J. A., Brown, S. C., Potter, A. C., Metzinger, L., Watt, D. J., Dickson, J G., Tinsley, J. M. and Davies, K. E. (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717-727 (Pubitemid 27357963)
21. Wehling-Henricks, M., Jordan, M. C., Roos, K. P., Deng, B. and Tidball, J. G. (2005) Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum. Mol. Genet. 14, 1921-1933 (Pubitemid 41418029)
22. Adamo, C. M., Dai, D. F., Percival, J. M., Minami, E., Willis, M. S., Patrucco, E., Froehner, S. C. and Beavo, J. A. (2010) Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 107, 19079-19083
23. Khairallah, M., Khairallah, R. J., Young, M. E., Allen, B. G., Gillis, M. A., Danialou, G., Deschepper, C. F., Petrof, B. J. and Des Rosiers, C. (2008) Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency. Proc. Natl. Acad. Sci. U.S.A. 105, 7028-7033 (Pubitemid 351754524)
24. Peluffo, R. D. (2007) L-Arginine currents in rat cardiac ventricular myocytes. J. Physiol. 580, 925-936
25. Devés, R. and Boyd, C. A. R. (1998) Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 78, 487-545 (Pubitemid 28182902)
26. Lu, X., Zheng, R., González, J., Gaspers, L., Kuzhikandathil, E. and Peluffo, R. D. (2009) L-Lysine uptake in giant vesicles from cardiac ventricular sarcolemma: two components of cationic amino acid transport. Biosci. Rep. 29, 271-281
27. Chang, F. J., Lemme, S., Sun, Q., Sunahara, R. K. and Beuve, A. (2005) Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase. J. Biol. Chem. 280, 11513-11519 (Pubitemid 40418462)
28. Hofmann, F., Feil, R., Kleppisch, T. and Schlossmann, J. (2006) Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol. Rev. 86, 1-23
29. Hecker, M., Sessa, W. C., Harris, H. J., Anggard, E. E. and Vane, J. R. (1990) The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. U.S.A. 87, 8612-8616
30. Wu, G. Y. and Brosnan, J. T. (1992) Macrophages can convert citrulline into arginine. Biochem. J. 281, 45-48
31. Zhou, J., Kim, D. D. and Peluffo, R. D. (2010) Nitric oxide can acutely modulate its biosynthesis through a negative feedback mechanism on L-arginine transport in cardiac myocytes. Am. J. Physiol. 299, C230-C239
32. Shanmugam, M., Gao, S., Hong, C., Fefelova, N., Nowycky, M. C., Xie, L. H., Periasamy, M. and Babu, G. J. (2011) Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovasc. Res. 89, 353-361
33. Domino, S. E., Tubb, D. J. and Garbers, D. L. (1991) Assay of guanylyl cyclase catalytic activity. Methods Enzymol. 195, 345-355
34. Sayed, N., Kim, D. D., Fioramonti, X., Iwahashi, T., Durán, W. N. and Beuve, A. (2008) Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ. Res. 103, 606-614
35. Zhou, J. and Peluffo, R. D. (2010) D-Enantiomers take a close look at the functioning of a cardiac cationic L-amino acid transporter. Biophys. J. 99, 3224-3233
36. Moore, P. K., Babbadge, R. C., Wallace, P., Graffen, Z. A. and Hart, S. L. (1993) 7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108, 290-291
37. Mayer, B., Klatt, P., Werner, R. and Schmidt, K. (1994) Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole. Neuropharmacology 33, 1253-1259
38. Rairigh, R. L., Storme, L., Parker, T. A., Le Cras, T. D., Markham, N., Jakkula, M. and Abman, S. H. (2000) Role of neuronal nitric oxide synthase in regulation of vascular and ductus arteriosus tone in the ovine fetus. Am. J. Physiol. 278, L105-L110 (Pubitemid 30104181)
39. Percival, J. M., Anderson, K. N., Huang, P., Adams, M. E. and Froehner, S. C. (2010) Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. J. Clin. Invest. 120, 816-826
40. Hare, J. M. (2003) Nitric oxide and excitation-contraction coupling. J. Mol. Cell. Cardiol. 35, 719-729
41. Bia, B. L., Cassidy, P. J., Young, M. E., Rafael, J. A., Leighton, B., Davies, K. E., Radda, G. K. and Clarke, K. (1999) Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J. Mol. Cell. Cardiol. 31, 1857-1862 (Pubitemid 29458703)
42. v1.5 by utrophin in dystrophin-deficient mice. Cardiovasc. Res. 89, 320-328